[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-32381":3,"doc-seo-32381":28},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":25,"seo_title":13,"seo_description":14,"update_tm":26,"read_time":27},32381,13056703020460,"Valentina","https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923",7,"Healthcare","Testosterone Therapy in Adult Males with Hypogonadism Luca Boeri","Testosterone therapy for adult males with hypogonadism focuses on the clinical rationale, expected benefits, and commonly evaluated outcomes in European urology practice. The paper addresses the medical basis for treating androgen deficiency, including therapeutic goals and the assessment of treatment response. It also considers safety and monitoring themes used in professional guidelines, using the journal and author context to frame evidence-based clinical decision-making for patient care.","cbCaiuwWeeWAdWaO","https://ap.wps.com/l/cbCaiuwWeeWAdWaO","pdf",757681,2,1,12,"English","en","# Overview of Testosterone Therapy for Hypogonadism\n## Clinical Rationale and Therapeutic Goals\n## Outcomes and Safety Considerations","[{\"question\":\"What condition does the document focus on?\",\"answer\":\"The document focuses on testosterone therapy for adult males with hypogonadism, i.e., clinically relevant testosterone deficiency.\"},{\"question\":\"What are the main aims of treatment discussed?\",\"answer\":\"It emphasizes clinical rationale and therapeutic goals, including expected improvement in hypogonadal-related outcomes and monitoring of treatment response.\"},{\"question\":\"How does the document address safety in testosterone therapy?\",\"answer\":\"It highlights safety and monitoring considerations commonly addressed in professional medical guidance and clinical practice.\"}]",1781130417,30,{"code":4,"msg":29,"data":30},"ok",{"site_id":31,"language":23,"slug":32,"title":13,"keywords":33,"description":14,"schema_data":34,"social_meta":85,"head_meta":87,"extra_data":89,"updated_unix":26},105,"testosterone-therapy-in-adult-males-with-hypogonadism-luca-boeri","",{"@graph":35,"@context":84},[36,52,67],{"@type":37,"itemListElement":38},"BreadcrumbList",[39,43,46,49],{"item":40,"name":41,"@type":42,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":44,"name":45,"@type":42,"position":19},"https://docshare.wps.com/document/","Document",{"item":47,"name":12,"@type":42,"position":48},"https://docshare.wps.com/document/healthcare/",3,{"item":50,"name":13,"@type":42,"position":51},"https://docshare.wps.com/document/testosterone-therapy-in-adult-males-with-hypogonadism-luca-boeri/32381/",4,{"url":50,"name":13,"@type":53,"author":54,"headline":13,"publisher":56,"fileFormat":59,"description":14,"dateModified":60,"datePublished":61,"encodingFormat":59,"isAccessibleForFree":62,"interactionStatistic":63},"DigitalDocument",{"name":9,"@type":55},"Person",{"url":40,"name":57,"@type":58},"DocShare","Organization","application/pdf","2026-06-11","2026-06-10",true,{"@type":64,"interactionType":65,"userInteractionCount":19},"InteractionCounter",{"@type":66},"ViewAction",{"@type":68,"mainEntity":69},"FAQPage",[70,76,80],{"name":71,"@type":72,"acceptedAnswer":73},"What condition does the document focus on?","Question",{"text":74,"@type":75},"The document focuses on testosterone therapy for adult males with hypogonadism, i.e., clinically relevant testosterone deficiency.","Answer",{"name":77,"@type":72,"acceptedAnswer":78},"What are the main aims of treatment discussed?",{"text":79,"@type":75},"It emphasizes clinical rationale and therapeutic goals, including expected improvement in hypogonadal-related outcomes and monitoring of treatment response.",{"name":81,"@type":72,"acceptedAnswer":82},"How does the document address safety in testosterone therapy?",{"text":83,"@type":75},"It highlights safety and monitoring considerations commonly addressed in professional medical guidance and clinical practice.","https://schema.org",{"og:url":50,"og:type":86,"og:title":13,"og:site_name":57,"og:description":14},"article",{"robots":88,"canonical":50},"index,follow",{"doc_id":7,"site_id":31}]